N-[1-(2-Methyl-1,3-thiazol-4-yl)ethyl]-1-(pyridin-2-yl)piperidin-4-amine

Catalog No. :
ACQIZL439
CAS No. :
1156781-45-1
Molecular Formula :
C16H22N4S
Molecular Weight :
302.45

IUPAC Name:N-(1-(2-methylthiazol-4-yl)ethyl)-1-(pyridin-2-yl)piperidin-4-amine

N-[1-(2-Methyl-1,3-thiazol-4-yl)ethyl]-1-(pyridin-2-yl)piperidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[1-(2-Methyl-1,3-thiazol-4-yl)ethyl]-1-(pyridin-2-yl)piperidin-4-amine
IUPAC NameN-(1-(2-methylthiazol-4-yl)ethyl)-1-(pyridin-2-yl)piperidin-4-amine
MDL No.MFCD13764775
Molecular FormulaC16H22N4S
Molecular Weight302.45
SMILESCC(NC1CCN(C2=NC=CC=C2)CC1)C3=CSC(C)=N3
InChI KeyYWFNTUMGROERIX-UHFFFAOYSA-N
SynonymN-[1-(2-methyl-1,3-thiazol-4-yl)ethyl]-1-(pyridin-2-yl)piperidin-4-amine;4-Piperidinamine, N-[1-(2-methyl-4-thiazolyl)ethyl]-1-(2-pyridinyl)-
CAS No.1156781-45-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQIZL439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWPF716 route compound structure diagram
    ACAWPF71623002-78-0 In Stock
  2. Plus
  3. ACNAEQ243 route compound structure diagram
    ACNAEQ243144465-94-1 In Stock
  4. Then
  5. ACQIZL439 route product structure diagram
    ACQIZL4391156781-45-1
Inquiry

2. ACQIZL439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVUCG973 route compound structure diagram
    ACVUCG973264608-41-5 In Stock
  4. Then
  5. ACQIZL439 route product structure diagram
    ACQIZL4391156781-45-1
Inquiry

Comments (0)